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Review 
 
 
Direct pulp-capping is a method for treating exposed vital pulp with dental material to facilitate the formation of reparative dentin 
and to maintain vital pulp. Two types of pulp-capping materials, calcium hydroxide and mineral trioxide aggregate, have been 
most commonly used in clinics, and an adhesive resin has been considered a promising capping material. However, until now, there 
has been no comprehensive review of these materials. Therefore, in this paper, the composition, working mechanisms and clinical 
outcome of these types of pulp-capping materials are reviewed. 
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INTRODUCTION 
 
There are three causes of vital pulp exposure: caries, 
mechanical sources and trauma. If pulp exposure occurs 
before caries is completely removed, it is considered caries 
exposure. If pulp exposure occurs during the preparation 
of a cavity without caries, it is called mechanical 
exposure. Mechanical exposures are  typically  due  to 
a misadventure during tooth preparation. Traumatic 
pulp exposure may result from a sports injury when 
the coronal part of the tooth is chipped. In the event of 
exposure in vital pulp, direct pulp-capping, pulpotomy 
or pulpectomy could be the treatment choices. 
Direct  pulp-capping  is  a  treatment  for  exposed 
vital pulp involving the placement of a dental material 
over the exposed area to facilitate both the formation 
of protective barrier1-3)  and the maintenance of vital 
pulp4,5). From a more precise clinical perspective, direct 
pulp-capping is a clinical technique that lies between 
indirect pulp-capping and pulpotomy. Indirect pulp- 
capping is a procedure in which a material is placed on 
a thin partition of remaining dentin where no vital pulp 
exposure occurs. Pulpotomy differs from pulp-capping 
only in that a portion of the remaining pulp is removed 
before the capping material is applied. Accordingly, 
direct pulp-capping has been used as an alternative 
approach to the maintenance of vital pulp, thereby 
avoiding as many as 22 million annual definitive root 
canal treatments in the United States6). Of these cases, 
several million fail due to the recurrence of symptoms 
or through the detection of periradicular disease7,8). 
Stanley9) and Bender10) hypothesized that many tooth 
extractions and root canal treatments could have been 
avoided through the conservative approach of direct 
pulp-capping. 
Clinical pulp conditions related to patient symptoms 
are  to  be  considered  before  the  direct  pulp-capping 
material placement. For evaluating clinical pulp 
conditions, the most important test is pulp vitality. If 
the pulp vitality test is negative, pulp necrosis is 
diagnosed. If the pulp vitality test is positive, then we 
call the pulp vital pulp. A vital pulp can be divided 
into   three   different   categories   depending   on   the 
clinical  symptoms:  normal  pulp,  reversible  pulpitis, 
and irreversible pulpitis. Normal pulp has no clinical 
symptoms. Reversible pulpitis usually has a short-lived 
thermal sensitivity, which will disappear immediately 
once the thermal stimulation is removed. Irreversible 
pulpitis usually has spontaneous and/or lingering pain 
and it could also have referred pain. Pulp-capping could 
be performed on tooth with normal pulp or reversible 
pulpitis. Percussion, palpation, and periodontal probing 
test results should be within normal limits.   The 
radiograph should show normal apical tissue. The pulp 
exposure site should be less than 1 mm in diameter 
and stopping pulpal hemorrhage should be prerequisite 
before   direct   pulp-capping   material   placement.   If 
these requirements cannot be satisfied, the pulp-capping 
procedure is not recommended. 
This review summarizes the current status of direct 
pulp-capping materials. 
 
 
BRIEF HISTORY OF DIRECT PULP-CAPPING 
MATERIALS 
 
The first documented pulp-capping treatment was 
conducted in 1756 by Pfaff, using gold foil4). Since then, 
many agents have been recommended for direct pulp- 
capping11,12). However, due to insufficient or inappropriate 
pre-treatment diagnoses, necrotic pulp was historically 
capped even though it was contraindicated11). 
In 1930, Hermann13,14) discovered that calcium 
hydroxide is effective in repairing an exposure site. 
Since then, calcium hydroxide in the form of powder, 
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paste and cement has been used with clinical success 
for facilitating the formation of reparative dentin along 
with the maintenance of vital pulp, the induction of 
mineralization and the inhibition of bacterial growth15,16). 
Calcium-hydroxide-based   cement   was   patented   in 
196217), and the first clinical study of Dycal (Dentsply 
Caulk, Milford, DE, USA) was reported in 1963, with a 
success rate of 85% compared with that of 80% for the 
control calcium hydroxide mixed with saline18). 
Glass and his colleagues4)  introduced zinc oxide 
eugenol for direct pulp-capping. However, chronic 
inflammation and a lack of pulp healing were observed, 
with no dentin bridge formation. It was later reported 
that eugenol is highly toxic, and zinc oxide eugenol 
resulted in high interfacial leakage19-22). 
In the 1970s, glucocorticoids combined with 
antibiotics were frequently used in an attempt to control 
pulpal pain and suppress pulpal inflammation19,20,23). 
Reports of poor wound-healing and even pulpal necrosis 
emerged, so steroids are no longer used for direct pulp- 
capping. 
For direct pulp-capping, the use of biological 
molecules, such as growth factors and extracellular 
matrices, is considered24). For example, animal studies 
showed that growth factors such as bone morphogenetic 
proteins (BMP) and transforming growth factors (TGF) 
induced reparative dentin formation21,24-27). However, 
these growth factors are not adequately therapeutic, 
since they produce a porous osteodentin with tunnel 
defects24). Extracellular matrix (ECM) dentin molecules, 
such as bone sialoprotein (BSP)28), matrix extracellular 
phosphoglycoprotein (MEPE)29), amelogenin24) and dentin 
phosphophoryn30), have been shown to induce reparative 
dentin. Capping with ECM molecules is extremely 
promising, producing a reparative mineralized tissue 
with structural properties better than those produced 
in the presence of calcium hydroxide24). Among these, 
amelogenin is suggested to be most promising as a direct 
capping material. Implantation of two spliced forms of 
amelogenin with agarose beads as carriers induced the 
formation of a homogeneous dentinal bridge or massive 
pulp mineralization24). 
Direct pulp-capping with resin-modified glass 
ionomer has been successfully reported in animal 
studies  in  monkeys31,32)    and  in  dogs33).  However,  it 
was also examined in humans34), and no dentin bridge 
formation was observed in 10 months. 
In the 1990s, Torabinejad and White35)  introduced, 
mineral trioxide aggregate (MTA), which is basically 
a hydraulic Portland cement or calcium silicate and 
releases calcium hydroxide slowly while setting. MTA 
has  been  used  clinically  with  success  rates  similar 
to  those achieved  with  calcium hydroxide36). In  2006 
and thereafter, MTA-like materials were launched, 
composed of artificial synthetic calcium silicates instead 
of Portland cement. 
 
CURRENT DIRECT PULP-CAPPING MATERIALS 
 
Calcium hydroxide 
Calcium hydroxide has been the gold standard for pulp- 
capping. The effect of calcium hydroxide is regarded as 
the result of the chemical injury caused by the hydroxyl 
ions. The initial effect of calcium hydroxide applied to 
exposed pulp is the development of a superficial necrosis. 
Firm necrosis causes slight irritation and stimulates the 
pulp to defend and repair to form a reparative dentin 
bridge through cellular differentiation, extracellular 
matrix secretion and subsequent mineralization37). While 
the formation of a dentin bridge has been believed to be 
the key for the clinical success of direct pulp-capping, 
it has been reported that 89% of dentin bridges formed 
by calcium hydroxide cement in monkeys contained 
tunnel defects38). These tunnel defects that form in the 
heterogeneous dentin bridge not only fail to provide a 
permanent barrier, but also fail to provide a long-term 
biological seal against bacterial infection. Another 
disadvantage  of  calcium  hydroxide  is  dissolution39). 
This may lead to the formation of a dead space40)  and 
microleakage39). 
 
1. Aqueous calcium hydroxide 
Historically, calcium hydroxide powder was applied 
directly onto the exposed pulp surface. The powder comes 
into contact with pulpal fluid and forms a paste41,42). 
This technique is not widely used at the present time. 
In a study in dogs, Eleazer et al.43) reported that calcium 
hydroxide powder in contact with the pulp caused an 
inflammatory response. Pereira et al.44), also in a dog 
pulp study, reported no differences in pulpal responses to 
direct pulp-capping achieved with either paste or powder 
forms in a 120-day period. Aqueous calcium hydroxide 
paste is used for direct pulp-capping45-47). This paste is 
generally prepared by the mixing of calcium hydroxide 
powder and water or saline at the time of application 
in the clinic. Premixed types of the paste indicated for 
direct pulp-capping are commercially available, such as 
UltraCal XS (Ultradent Products, South Jordan, UT, 
USA) and Calcicur (Voco, Cuxhaven, Germany), which 
also contain barium sulfate for radiopacity and other 
ingredients to enhance the properties of the material. 
The success rates of direct pulp-capping with calcium 
hydroxide decrease as follow-up periods increase. Rates 
are more than 90% after 1 to 2 years and drop from 82% 
to 37% after 2 to 5 years48), or to 80%, 68% and 59% after 
1, 5 and 9 years, respectively49). 
Although  aqueous  calcium  hydroxide  has  been 
well-accepted clinically, it has drawbacks, including a 
lack of setting properties and gradual resorption after 
placement. Another disadvantage is porosities in the 
newly formed dentin, known as tunnel defects, which 
can result in microleakage and lead to the loss of tooth 
vitality and calcification36). 
 
2. Calcium-hydroxide-based cement 
Because of the disadvantages of aqueous calcium 
hydroxide described above, a cement type of calcium 
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hydroxide with setting characteristics was developed 
and has been widely used in clinical practice since the 
1960s. 
The most popular commercial cement is Dycal, 
which consists of catalyst and base mixed at a 1:1 ratio. 
The catalyst contains calcium hydroxide, N-ethyl-o/p- 
toluene sulfonamide, zinc oxide, titanium dioxide and 
zinc stearate, and the base contains 1,3-butylene glycol 
disalicylate, zinc oxide, calcium phosphate and calcium 
tungstate. Another product is Life (Kerr, Orange, CA, 
USA), whose setting reaction mechanism between 
salicylic acid ester and zinc oxide is similar to that of 
Dycal, but whose ingredients are different. The base 
contains calcium hydroxide, zinc oxide and butyl benzene 
sulfonamide, and the catalyst barium sulfate, titanium 
dioxide and methyl salicylate. 
There are two clinical studies that applied calcium 
hydroxide cement for direct pulp-capping. Al-Hiyasat 
et al.50), using only radiography, evaluated the 3-year 
treatment outcome of pulp-capping in teeth in terms of 
both mechanical and caries exposure. The success rate 
for mechanical exposure was 92% compared with 33% 
for the caries-exposure cases. In another study, Barthel 
et al.51), using both radiography and pulp vitality testing, 
examined the 5- and 10-year treatment outcome of caries 
exposure in pulp-capped teeth. In this case, the success 
rates for 5 and 10 years were 37% and 13%, respectively. 
The majority of the failures were asymptomatic; the pulp 
tended to become necrotic or slowly calcify. Therefore, 
direct pulp-capping is considered controversial by many 
clinicians, and pulpectomy is still the standard procedure 
for treating caries-exposed inflamed vital pulp with a 
closed apex. The success rate of pulpectomy is reported 
to be about 95%52,53). 
 
Calcium-silicate-based materials 
1. Hydraulic cements 
1) Mineral trioxide aggregate (MTA) 
The  original  MTA,  ProRoot  MTA  Gray  (Dentsply 
Tulsa  Dental  Specialties,  Johnson  City,  TN,  USA), 
was  marketed  in  1998  and  was  composed  of  75% 
Type I Portland cement, 20% bismuth oxide and 5% 
calcium sulfate dihydrate. The Portland cement is 
composed of approximately 55 wt% tricalcium silicate 
(3CaO•SiO2), 19 wt% dicalcium silicate (2CaO•SiO2), 
10  wt%  tricalcium  aluminate  (3CaO•Al2O3),  7  wt% 
tetracalcium aluminoferrite (4CaO•Al2O3•Fe2O3), 2.8 
wt% magnesium oxide, 2.9 wt% sulfate and 1.0 wt% free 
calcium oxide. Bismuth oxide and calcium sulfate are the 
radiopacifier and setting modifier, respectively. ProRoot 
MTA White was introduced in 2002 and differs from 
its predecessor in composition, i.e., the elimination of 
tetracalcium aluminoferrite and an increase of calcium 
silicates. The gray type of MTA, containing tetracalcium 
aluminoferrite, and with composition similar to that of 
the original type, is less popular for esthetic reasons, 
but several products are available, including: ProRoot 
MTA Gray, MTA Angelus (Angelus, Londrina, Brazil), 
Grey MTA Plus (Avalon Biomed, Bradenton, FL, USA), 
EndoCem  MTA  (Maruchi,  Gangwon-do,  Korea)  and 
Ortho MTA (BioMTA, Daejeon, Korea). MTA without 
tetracalcium aluminoferrite is more popular, and many 
products are marketed worldwide: ProRoot MTA White, 
MTA Angelus White, White MTA Plus (Prevest Denpro, 
Jammu, India), MM-MTA (Micro Mega SA, Besançon, 
France), MTA Caps (Acteon, Merignac, France), Tech 
BioSeal MTA (Isasan S.R.L., Rovello Porro, Italy), 
Aureose l  M.T.A.  (Ogna  Laboratori  Farmaceutici, 
Muggiò, Italy), MTA+product (Cerkamed PPH, Wojciech 
Pawlowski, Nisko, Poland), Trioxident (VladMiVa, 
Belgorod, Russia), NEX MTA (GC, Tokyo, Japan) and 
Endo-Eze MTA (Ultradent Products), among others. 
The mechanism of action of MTA is similar to that of 
calcium hydroxide. The calcium hydroxide produced as a 
by-product of hydration of MTA is leached out and causes 
necrosis when in contact with the pulp. When MTA 
powder is mixed with water at the time of application, 
calcium silicates in the powder hydrate to produce a 
calcium silicate hydrate gel and calcium hydroxide, as 
shown below: 
2[3CaO•SiO2]+6H2O→3CaO•2SiO2•3H2O+3Ca(OH)2 
2[2CaO•SiO2]+4H2O→3CaO•2SiO2•3H2O+Ca(OH)2 
Thus, MTA can be described as a calcium-hydroxide- 
releasing material and, therefore, is expected to present 
various properties similar to those described above for 
calcium hydroxide. 
The advantages of MTA are believed to be its sealing 
ability, biocompatibility, bioactivity and capacity to 
promote mineralized tissue formation54-57).  Also, MTA 
is suggested to be superior to calcium hydroxide due to 
its more uniform and thicker dentin bridge formation, 
less inflammatory response and less necrosis of pulpal 
tissue55,56,58-63). 
An antibacterial effect of MTA is controversial as 
reviewed by Parirokh and Torabinejad64). MTA showed 
an antibacterial effect on some of the facultative bacteria 
but no effect on any of the strictly anaerobic bacteria65). 
MTA demonstrated, in some cases, albeit inferior to 
calcium hydroxide or zinc oxide/eugenol paste66-70). Taken 
together, the antimicrobial activity of MTA may not be 
as strong as those of traditional calcium hydroxide-based 
cements and sealers70). 
In spite of its many positive properties, some 
disadvantages  of  MTA  include  long  setting  times, 
poor handling71-73), and coronal tooth discoloration74-77). 
Reported setting times have shown variations: 50 min73), 
less than 4 h78)  and 70 and 175 min for the initial and 
final setting times79), respectively. Setting time of MTA 
Gray (165 min) is shorter than that of MTA White64). A 
long setting time may be inconvenient to both dentist 
and  patient,  because  it  requires  direct  pulp-capping 
with MTA in two visits: application of MTA in the first 
visit and seating of the permanent restoration over the 
sufficiently hardened MTA in the second visit. Moreover, 
it may increase the risk of bacterial contamination. 
Short setting times will make it possible for treatment 
to be performed in one visit. 
As for the handling characteristics, the “sandy”- 
feeling mixture produced by the coarse particles of 
ProRoot and water is difficult to be delivered to the 
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required site and hard to condense adequately. Setting 
time and handling properties can be affected by the 
particle size and distribution as well as by the shape 
of the MTA powder. The particle sizes of MTA are 
reported to be from 1 to 10 μm80). Angelus White and 
Gray have median particle size below 10 μm, but contain 
many particles more coarse than 40 μm, up to 100 μm. 
Comparisons of particle size and shape were reported 
among ProRoot MTA, MTA Angelus and ordinary 
Portland cement. The Angelus particles had relatively 
low circularity and wide size distribution and were less 
homogeneous than ProRoot MTA, and ProRoot MTA 
Gray had many similarities to Portland cement in 
particle size and distribution. Some particles of MTA 
were as small as 1.5 μm81). Size distribution in ProRoot 
Gray is greater than in the White82,83). 
Tooth discoloration has been reported with the use 
of gray MTA in direct pulp capping74) and therefore the 
use of  white MTA  has generally been recommended 
in the esthetic zone. However, tooth discoloration 
associated with white MTA was also described in case 
reports in endodontic treatments75,76). Tooth color change 
was reported to be induced by both gray and white MTA 
in vitro77). Several factors were reported to contribute 
to  tooth  discoloration by  white  MTA:  contamination 
with  blood84,85),  contact  with  sodium  hypochlorite86), 
the presence of light and oxygen87,88). The possible 
involvement of the radiopacifier bismuth oxide in the 
discoloration is postulated87). The reason and mechanism 
of tooth discoloration are not fully understood and 
remain to be investigated. 
MTA cannot bond to dentin. Therefore, there is a 
risk of bacterial leakage, which could lead to failure of 
endodontically treated teeth. The sealing ability of MTA 
as a root-end filling material was evaluated and compared 
with that of other materials in vitro by several methods. 
In dye penetration tests, the ascending order of leakage 
was reported as: MTA<glass-ionomer cement<Super 
EBA (Bosworth Company, Skokie, IL, USA) [reinforced 
zinc oxide/eugenol (32%)/o-ethoxybenzoic acid (68%) 
cement]<amalgam<IRM (Intermediate Restorative 
Material, Dentsply Caulk, Milford, DE, USA) (reinforced 
zinc oxide-eugenol cement)89-91). A bacterial microleakage 
model study showed: composite resin (Prisma TPH, 
Dentsply Caulk)<amalgam+bonding agent (Probond 
Primer & Adhesive, Dentsply Caulk)<EBA, amalgam 
and MTA92). Another bacterial leakage study indicated 
that MTA and EBA leaked, and that leakage increased 
with  time93).  The  results  of  a  fluid  transport  model 
study were: AH26 (Dentsply Maillefer, Ballaigues, 
Switzerland) (negative control)<<MTA<glass-ionomer 
cement<EBA<amalgam94). The results of marginal 
adaptation  measurement  indicated  that  MTA  was 
better  than  IRM  and  Super  EBA95).  A  dye  leakage 
study in the orifice of a root canal system indicated: 
composite resin (Tetric, Ivoclar Vivadent, Schaan, 
Liechtenstein)<MTA<Cavit (3M ESPE, St. Paul, MN, 
USA) [zinc oxide/ethylene bis(oxyethylene)diacetate 
cement]96). 
When  all  these  results  are  summarized,  it  may 
be concluded that MTA is better than glass-ionomer 
cement, EBA cement, amalgam and IRM, but inferior to 
composite  resin  and  AH26,  which  is  a  root  canal 
sealer consisting of epoxy resin, methenamine 
(hexamethylenetetramine)  and  bismuth  oxide.  Thus, 
it is suggested that the seal provided by MTA should 
probably be more leakage-proof97). 
Animal direct pulp-capping studies comparing MTA 
with calcium hydroxide generally indicate better pulp- 
healing with MTA than with calcium hydroxide59,60,62,98-102). 
These studies consistently demonstrated more hard- 
tissue bridge formation and less inflammation in the 
MTA  group  compared  with  the  calcium  hydroxide 
group. Also  in  human studies, many  reports agreed 
that MTA is better than Dycal, with better hard-tissue 
formation and less pulp tissue inflammation61,97,103,104). 
The biological mechanism by which MTA induces dentin 
bridge formation is currently unknown. The predictable 
formation of a quality hard-tissue barrier subjacent to 
MTA is likely to be multifactorial, involving its sealing 
ability, biocompatibility and the production of an alkaline 
pulpal environment97). 
As for clinical outcome of direct pulp-capping with 
MTA, Miles and colleagues105) reported on caries-exposed 
permanent teeth with closed apex. Overall, the one- 
year pulp survival was 68%, while the two-year survival 
rate was 56%. A recent study87)  showed that MTA and 
calcium hydroxide had a successful outcome of 78% and 
60%, respectively. Teeth that were permanently restored 
within 2 days after being capped had a better prognosis, 
and there was no difference between mechanical and 
caries pulp exposure106). Regarding caries-exposed pulp 
with an open apex in young immature tooth, MTA 
showed high clinical success in both primary107)  and 
permanent teeth74,108) in periods ranging from six months 
to four years. 
 
2) Modified MTAs and MTA-like materials 
Some modified MTAs overcoming the drawbacks of the 
original MTA are available, and most of them aimed 
to shorten setting time by modifying the composition 
or particle size of the powder. In Angelus White MTA 
(setting time, 15 min), calcium sulfate was removed and 
calcium oxide was added to tricalcium silicate, dicalcium 
silicate, tricalcium aluminate and bismuth oxide109). In 
MM-MTA, calcium carbonate was added; in Tech BioSeal 
MTA, calcium chloride and montmorillonite were added; 
and the powder in MTA Plus was more finely ground. 
MTA-like  materials  were  marketed  after  2006. 
They are not composed of Portland cement, which is 
manufactured from minerals of natural origin, but 
consist of synthetic calcium silicates as the main 
components  and  are  aluminum-free.  The  difference 
in origin of calcium silicates is clearly demonstrated 
in the release of metal ions from the set materials110). 
In Angelus MTA and MM-MTA, which are based on 
Portland cement, a large amount of aluminum and trace 
amounts of arsenic, beryllium, cadmium and chromium 
were detected, but in DiaRoot Bioaggregate (DiaDent 
Group  International,  Cheongju-si,  Korea),  based  on 
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synthetic  calcium  silicates,  no  metals  were  detected 
except a trace amount of aluminum. 
BioAggregate, marketed in 2006, consists of 
tricalcium silicate, dicalcium silicate, tantalum 
pentoxide (radiopacifier), calcium phosphate monobasic 
(calcium dihydrogen phosphate) and amorphous silicon 
oxide. Calcium phosphate reacts with part of the calcium 
hydroxide produced from setting (hydrating) calcium 
silicates, and during the reaction, hydroxyapatite and 
water are formed. The water thus produced contributes 
to the hydration reaction speed. Silicon oxide also reacts 
with calcium hydroxide by the so-called pozzolanic 
reaction and thus contributes to setting time. The 
setting time is within 4 h at a normal optimal powder/ 
liquid ratio (1 g/0.38 mL water). The antibacterial effect 
was reported to be similar to Dycal and inferior to zinc 
oxide/eugenol cement111). 
Biodentine (Septodont, Lancaster, PA, USA), 
launched in 2009, contains tricalcium silicate, calcium 
carbonate and oxide and zirconium oxide (radiopacifier) 
in the powder, which is mixed with calcium chloride 
solution  containing  modified  polycarboxylate  instead 
of water. Both substances in the liquid contribute to 
shortened setting times (from 10 to 12 min). Calcium 
chloride accelerates the hydration reaction, and 
polycarboxylate reduces the amount of water required 
for mixing by providing proper consistency, which also 
contributes to easy handling of the mixture. Calcium 
carbonate in the powder is expected to act as a nucleation 
site in the hydrating mass, enhancing the hydration and 
leading to faster setting. Finer particles in the powder 
with larger specific surface areas can also contribute to 
short setting time: the specific surface area of Biodentine 
was reported to be about 2.8-fold compared with that of 
MTA Angelus White109). Biodentine was reported to have 
efficacy similar to that of MTA in direct capping over 
mechanically exposed molar pulps. Complete dentinal 
bridge formation, an absence of inflammatory pulp 
response and layers of well-arranged odontoblasts and 
odontoblast-like cells were observed after 6 weeks112). 
EndoSequence BC RRM (Brasseler USA, Savannah, 
GA, USA), introduced in 2009, includes tricalcium 
silicate, dicalcium silicate, tantalum pentoxide, 
zirconium  oxide,  calcium  dihydrogen  phosphate, 
calcium hydroxide and thickening agent and is used as 
a premixed-syringeable paste or putty without being 
mixed with water. Recently, in 2014, BC RRM-Fast Set 
Putty has been launched, which is made with a fast-set 
formula and equipped with a syringe delivery system. In 
this material, water required to hydrate calcium silicates 
depends on the presence of a natural source in dentin. 
The calcium silicates in the powder hydrate to produce 
a calcium silicate hydrate gel and calcium hydroxide. 
The calcium hydroxide reacts with the phosphate ions 
to precipitate hydroxyapatite and water. The water 
continues to react with the calcium silicates to precipitate 
additional gel-like calcium silicate hydrate. The water 
supplied through this reaction is an important factor 
in controlling the hydration rate and the setting time. 
Setting time is ~2 h for RRM and 20 min for BC RRM-Fast 
Set Putty, according to the manufacturer. However, this 
appears questionable because the experiment studying 
the effect of the addition of water to the material showed 
a tendency for the initial setting time to increase (from 
about 75 h to 110 h) and the final setting time to decrease 
(from about 240 h to 170 h) when increasing amounts of 
water were added (from 1% to 9%)113). The largest particle 
size of the powder was 0.35 μm, with approximately 50% 
of the particles being nano (1×10−3  μm) in size114). This 
material was shown to have cytotoxicity levels similar 
to those of ProRoot MTA and MTA Angelus114). BC RRM 
putty has similar in vitro biocompatibility to MTA115). It 
had similar results compared with MTA when used as 
pulp-capping agents116)  and induced the proliferation of 
dental pulp cells and the formation of reparative dentin 
bridge117). 
 
2. Resin-modified MTA cement 
TheraCal LC (Bisco, Schaumburg, IL, USA) is a light- 
curing, resin-modified calcium-silicate-filled single paste, 
containing calcium oxide, calcium silicate particles (type 
III Portland cement), strontium glass, fumed silica, 
barium sulphate, barium zirconate and resin consisting 
of Bis-GMA and polyethylene glycol dimethacrylate118). 
The formation and leaching of calcium hydroxide were 
shown to be negligible, and little or no hydration was 
exhibited118). The inflammatory response was more 
intense than with MTA Angelus, and this material did 
not stimulate mineralizaion119). 
 
Resin-based cements 
1. Composite and MMA-based cements 
As described above, at present, the sealing ability of 
the materials based on inorganic compounds used as 
the clinical standard needs further improvement, and 
adhesive resins should be helpful in this regard. The 
effectiveness of adhesives has been demonstrated in 
vitro and in vivo. A bonded coronal seal of either core 
paste (composite resin build-up material) and Tenure 
adhesives, or amalgam and Panavia, was reported to 
result in virtually no penetration of the India ink in 
which the teeth had been immersed for 10 days120). 
Cox et al.121) investigated the effect on pulp of calcium 
hydroxide capping and restoration with amalgam for 
cavities with exposed pulps in monkeys. Half of those 
pulps showed complete healing, and the remainder 
presented pulp inflammation of severity varying from 
localized low-grade accumulations of mononuclear 
leukocytes to extensive breakdown of the pulp tissue with 
abscess formation and necrosis after 1 and 2 years. This 
study demonstrated that recurring pulp inflammation 
was associated with bacterial contamination and 
implied the need for effective sealing of the exposure 
site to prevent marginal leakage of bacteria. Although 
a dentin bridge was formed by calcium hydroxide, it 
was reported that the bridge was heterogeneous and 
contained tunnel defects38). MTA was also reported to 
form tunnel defects59,122). 
For effective tooth sealing, adhesive resins should 
be  helpful.  In  animal  studies123-126),  successful  pulp 
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healing and dentin bridge formations have been reported 
when adhesive resins were used for direct pulp-capping. 
However, in the literature, including several histology- 
based reports of direct pulp-capping for mechanically 
exposed human teeth, the situation is different. Bonding 
agents  such  as  All  Bond  2  (Bisco)127),  Clearfil Liner 
Bond 2 (Kuraray, Tokyo, Japan)128), Scotch Bond Multi- 
Purpose (3M ESPE)129), Single Bond (3M ESPE)130)  and 
composite resin (Z100) (3M ESPE) were applied to the 
pulp for periods ranging from 2 to 10 months. Calcium- 
hydroxide-based cement (Dycal) was used as a control in 
all cases. These reports concluded that Dycal is better 
than the resin systems, possibly due to the effect of 
residual monomer on the vital pulp. 
Monomer cytotoxicity can affect vital pulp in the 
short term, before setting, or in the long term, after 
setting131-133). Before setting, the cytotoxicity of the 
monomer itself will affect the pulp, while after setting, 
the effect of residual monomer contained in the set resin 
will depend on the amount and elution kinetics of the 
monomer. 
Cytotoxicity testing of 39 monomers used in dental 
materials revealed that methyl methacrylate (MMA) 
was least cytotoxic134). Other reports indicate similarly 
the lowest cytotoxicity for MMA135,136).  Because of the 
low toxicity of MMA, MMA-based resin has long been 
successfully, and widely used for bone cements to anchor 
artificial joints in orthopedic surgery. 
The inferior outcome of the resin systems used for 
direct pulp-capping compared with Dycal may be due 
to the high cytotoxicity of the monomers used in those 
systems. In terms of monomer cytotoxicity, the MMA- 
based resin should be the best option for a pulp-capping 
resin. The minimal effect of MMA on pulp tissue has 
been   reported.   Pulp   tissues  removed   from   rabbit 
incisors were immersed in MMA for 1 min. The MMA- 
immersed and the untreated control pulp tissues were 
autotransplanted beneath the kidney capsule. The 
MMA-immersed pulp and the untreated control pulp 
tissue were positive for osteocalcin and presented 
osteodentin formation at 7 days. This suggested that 
MMA did not inhibit the osteogenic activity of pulp 
tissue137). 
An in vivo comparison of MMA-based resins with 
composite resin has been published by Tronstad and 
Spångberg138). The pulp responses to Bis-GMA-based 
composite resin (Concise) (3M, St. Paul, MN, USA) and 
MMA-based resins initiated by sulfinic acid (Sevriton, 
de Trey, Zürich, Switzerland) or tributylborane (TBB) 
(Polycap, Ivoclar Vivadent) in deep Class V cavities in 
monkeys were compared. After 8 days, the degrees and 
percentages of responses were slight, moderate and 
severe in this order: 30%, 50% and 20% for Concise; 30%, 
20% and 50% for Sevriton; and 75%, 25% and 0% for 
Polycap, respectively. No severe response was seen in 
Polycap. Overall, the severity of the pulp response was 
lowest for Polycap compared with that of Concise and 
Sevriton. The remarkable difference in the responses 
between Sevriton and Polycap is noteworthy because 
both resins are composed basically of MMA monomer, 
but the polymerization initiator is different. This 
suggests that the pulp response to resins is significantly 
affected by not only the type of resin monomer but also 
by the polymerization initiator (catalyst). In the paper 
cited above138), no material information on the resins was 
provided. From the literature, the catalyst of Sevriton 
is known to be sulfinic acid139), but no information on 
Polycap is available. However, the statement in the 
discussion citing two papers140,141)  clearly suggests that 
Polycap was actually the same material as Palakav 
(Firma Kulzer, Hanau, Germany) and its premarketing 
material F1, which were MMA-based resins initiated by 
TBB (MMA-TBB resin). It was reported that Polycap is 
a joint product of Vivadent and Kulzer142). 
 
2. MMA-TBB resin cement 
A successful clinical trial of the MMA-TBB resin was 
reported in 1968, indicating a minimal pulp damage 
histologically  after  9–12  months  in  unlined  cavities 
of vital teeth by filling F1 (MMA-TBB resin)143,144). A 
similar favorable clinical result was reported in 1976. 
No pulpal necrosis or partial pulpitis could be observed 
after 2–35 months by filling Polycap (MMA-TBB resin) in 
unlined cavities of vital teeth142). Thus, MMA-TBB resin 
seems promising as a pulp-capping resin. Christensen 
has referred to 4-META bonding agent, which is the 
MMA-TBB resin containing 4-[2-(methacryloyloxy)- 
ethoxycarbonyl]phthalic anhydride (4-META), as a 
clinically successful bonding agent for pulp-capping145). 
In Japan, it has been used for direct capping with 
clinical success by practitioners experienced with the 
resin. Although clinical reports are scarce146-150), several 
in vitro and in vivo studies supporting clinical success 
have been published. 
Cellular activities of rat dental pulp cells cultured 
on 4-META/MMA-TBB resin (4-META resin for short) 
(SuperBond, Sun Medical, Moriyama, Japan) were 
comparable to control plastic plates, suggesting that the 
resin did not induce cytotoxic responses151). Cell viability 
of 4-META resin was reported to increase from 66% for 
fresh material to 100% for the set resin. This suggests 
that cytotoxicity of the resin was significantly reduced 
during the course of setting152). 
Evident dentin bridge formation was reported on the 
surgically exposed dental pulp in germ-free rats after 
application of 4-META resin153). Favorable periapical 
tissue healing in the rat molar after retrofilling with 
4-META resin was reported that the resin produced 
the least severe inflammatory reaction and the greatest 
amount of new bone, and thus fostered the natural 
regeneration of the periapical tissue154). Investigation 
of nerve regeneration and proliferative activity in 
amputated  pulp  tissue  of  dogs  after  the  application 
of 4-META resin or calcium hydroxide revealed that 
wound-healing of  the  exposed  pulp  surface  occurred 
for the resin in a manner similar to that with calcium 
hydroxide155). 
The best support for clinical success of the resin is 
provided by Inoue et al., who conducted comprehensive 
in vitro and in vivo studies of the resin. Their works have 
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also been summarized as review articles156,157). Important 
points from their studies will be referred to below. 
Cytotoxicity testing with L-929 cells by the Millipore 
filter  method  was  carried  out  by  the  placement  of 
4-META resin at 1, 5 and 10 min, and 1 and 24 h after 
the resin components were mixed on the filter. Bis-GMA 
resin (Panavia) (Kuraray) was also tested as a control. 
4-META resin showed only slight toxic effects up to 10 
min, at which time the resin was fully cured. However, 
the Bis-GMA resin showed moderate toxic effects up to 
60 min158). A cell proliferation test was performed on 
completely polymerized 4-META and Bis-GMA resins for 
up to 4 days. The results showed that the proliferation 
rate of the cells on 4-META resin was slower than that 
on the control (culture dish), but the cells remained 
viable over the test periods. The polymerized 4-META 
resin appeared to cause almost no cytotoxic damage to 
the cells. No cells were found on the Bis-GMA resin at 
any experimental period158). 
The 4-META resin was polymerized directly onto 
human  pulp.  The  tooth  with  the  polymerized  resin 
was treated with 36% hydrochloric acid to remove the 
pulp tissue underlying the resin and then treated with 
acetone to remove the polymerized resin. After these 
treatments, a thin layer of film was obtained, which 
the authors called the residual soft-tissue hybrid layer 
(STHL). SEM and TEM observation studies showed the 
presence of collagen fibers, cells and capillaries in the 
STHL. Moreover, XPS analysis showed the presence of 
nitrogen and sulfur on the STHL, indicating that this 
layer contained pulp tissue components156). These results 
clearly demonstrated graft polymerization of MMA to 
pulp tissue, which means that poly(methyl methacrylate) 
bonds chemically to pulp tissue. STHL is undoubtedly a 
graft polymer, although the authors did not refer to the 
formation of graft polymer. Generally, graft polymer is 
composed of a main backbone polymer to which different 
type of the branch polymers is chemically connected 
through covalent bonds. 
In vivo testing in humans was performed in 
premolars. After preparation of an occlusal cavity, the 
pulp was exposed and the cavity was filled with 4-META 
resin. The teeth were extracted at 7 to 294 days and 
observed histologically. Patients complained of neither 
pain nor hypersensitivity. The in vivo studies showed 
that: (1) only slight inflammatory cell infiltration was 
found in some cases in the early stage; (2) dentin bridge 
formation occurred in half of the experiment cases; and 
(3) macrophages appeared in some cases in the later 
stage. Based on these results, the authors concluded 
that 4-META resin could be used to conserve pulp 
because the resin had no cytotoxic effects on pulp and 
maintained a biological seal, which was achieved by the 
STHL described above. Thus, they stated that STHL 
might have a protective function on exposed pulp, much 
like that of a dentin bridge, and therefore might be called 
an “artificial dentin bridge”156,159).  Figure 1 illustrates 
the formation of a soft-tissue hybrid layer (STHL)156)  or 
“artificial dentin bridge”156)  in direct pulp-capping with 
MMA-TBB resin by graft polymerization and interfacial 
initiation of a polymerization mechanism160). 
There  are  four  probable  reasons for  the  success 
of   MMA-TBB   resin:   (1)   MMA   is   least   cytotoxic 
among the monomers used in dentistry134-136); (2) TBB 
initiator reduces the residual MMA after setting with 
time160,161); (3) TBB has the capacity to induce interfacial 
polymerization of MMA at the  dentin  interface160,162); 
and (4) TBB causes graft polymerization of MMA onto 
dentin collagen to produce a graft polymer composed of 
collagen and MMA polymer140,160). 
Reasons (1) and (2) appear to correlate with the 
results of the studies by Inoue et al.158,159), whose results 
showed that (a) 4-META resin demonstrated cytotoxicity 
in vitro only at the early period after the start of setting 
of the resin, and (b) the resin caused slight inflammatory 
cell infiltration in the early stage in vivo. It was reported 
that  residual  MMA  monomer  decreased  from  8.15% 
to 1.96%, 0.84% and 0.48% at 30 min, 24 h, 1 and 4 
weeks after the start of setting of MMA-TBB resin161). 
This significant decrease of the residual monomer with 
time can be correlated with cell responses in vitro and 
in vivo as described above. Moreover, dentin bridge 
formation in the human study was not always observed 
in all experimental cases, but occurred in half of the 
cases156,159).  The  absence  of  dentin  bridge  formation 
in half of the cases may be correlated to a weak 
inflammatory response caused by 4-META resin. In pulp 
repair, it is suggested that the initial mild inflammatory 
reaction as  caused by  calcium hydroxide  application 
is  a  prerequisite for  tissue  repair,  which  would  not 
occur if this essential step was omitted24). Therefore, 
an inflammatory reaction caused by the resin may 
sometimes fall below the level of mild reaction. 
The effects of reasons (3) and (4) enable reliable 
sealing of the interface to occur. These characteristics of 
TBB in polymerization will be correlated with favorable 
dental tissue responses in the filling of MMA-TBB resin 
in deep unlined cavities in clinical trials143,144)  and in 
animal studies, as described above. The comparison of 
polymerization behavior in a cavity model initiated by 
conventional benzoyl peroxide (BPO)/amine and TBB 
initiators is illustrated in Fig. 1. The polymerization 
of conventional restorative resins starts from the resin 
side, and the effect of polymerization shrinkage occurs 
between the dentin and resin. However, according to 
the report by Imai et al.162), the polymerization of MMA- 
TBB resin starts from the dentin interface. The dentin 
interface is thus sealed tightly with the resin, in 
cooperation  with  excellent  dentin  bonding  property 
of the resin through the graft polymer formation 
mechanism. While the shrinkage of resins creates space 
in conventional resin, MMA-TBB produces minimum 
space, which leads to less leakage compared with that 
of conventional resins. The apical sealing ability of 
MMA-TBB resin was reported to be significantly better 
compared with that of gutta-percha/sealer and root 
canal filling of the resin formed resin tags in dentinal 
tubules163). This excellent seal helps protect against 
bacterial contamination, the importance of which in 
pulp-capping was suggested by Cox et al.121) 
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Fig. 1    Formation of Artificial Dentin Bridge (ADB) or Soft-Tissue Hybrid Layer (STHL) in 
direct pulp-capping with MMA-TBB resin by graft polymerization and interfacial 
initiation of polymerization mechanism. 
A: Exposure of vital pulp. B: Direct pulp-capping with MMA-TBB resin and formation 
of ADB/STHL, which consists of collagen-PMMA graft polymer. Interfacial initiation 
of polymerization begins on the dentin side, to which the resin is attracted during 
polymerization, leading to elimination of gap formation between dentin and the resin. 
C: Dentin bridge formation, which occurred in half of the experiments156). 
 
 
 
Generally pulp capping should be performed in 
cases with no clinical symptoms and with normal clinical 
examination. If pulp capping need to be performed in 
pulp that is suspected of having limited inflammation, 
such as pulp exposure during or after removing caries, 
calcium hydroxide/MTA  would be  the  choice instead 
of MMA-TBB resin. Since MMA-TBB resin does not 
possess bactericidal action, MMA-TBB resin will be used 
clinically only for uninfected pulp. 
 
 
FUTURE CONSIDERATIONS FOR PULP-CAPPING 
MATERIAL 
 
The success rate of direct pulp-capping is inferior to 
that of pulpectomy. Current materials lack effectiveness 
mainly because of leakage at the interface between the 
dentin and pulp-capping material as well as restorative 
material. For the development of future pulp-capping 
materials, the use of ECM may be considered an option, 
as suggested by Goldberg et al.24,27). The other is the 
application of high-quality dentin adhesive material with 
the  capability  of  initiating  interfacial polymerization 
for restorative  material  over the  direct  pulp-capping 
leakage and enhance long-term success. In this respect, 
MMA-TBB resin is useful not only for restoration but 
also for direct pulp-capping in the future. The reason is 
as follows: While it takes at least one week for calcium 
hydroxide and MTA to form a natural dentin bridge, one 
day is enough for MMA-TBB resin to form an “artificial 
dentin bridge”. Rapid formation of a pulp-protective 
barrier against bacterial contamination should be 
desirable to minimize the damage to the pulp. Moreover, 
the former natural bridges sometimes have tunnel 
defects, but the latter impermeable “artificial bridge” 
has no such defect. MTA/MTA related materials and 
MMA-TBB resin have the advantages of anti-bacterial 
effects and rapid formation of a pulp-protective barrier, 
respectively. Therefore, in the future, both materials 
may be chosen depending on each clinical case for direct 
pulp-capping. The addition of anti-bacterial substrates 
to the resin may plus another advantage. It is expected 
that MMA-TBB resin will be widely accepted worldwide 
in clinical practice in the future, although only limited 
numbers of clinicians in Japan are using it. For the 
resin to be widely used, it must receive official approval 
as  a  direct-capping  material,  because  the  present 
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pulp-capping is not included in the indications for use. 
Therefore, currently, the resin is used at the dentist’s 
discretion. 
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